Abstract The purpose of this study was to evaluate the utility of a breast cancer risk assessment (BCRA) at the time of screening mammogram. Women whose BCRA indicated a high risk for cancer received a letter with instructions for breast health care and genetic counseling if appropriate. After 6 months this group received surveys to evaluate their risk perception and their recall of, and compliance with, recommendations. We also explored the impact of other variables such as a recommendation for genetic counseling and physician communication with the women. After the BCRA, the majority of high risk women reported no change in their perceived risk of cancer. A woman's perceived risk of cancer after a BCRA was significantly associated with her recall of recommendations for breast health care, but not with compliance. A recommendation for genetic counseling was not significantly related to women's perceived risk of cancer after the BCRA. Ten percent of women who should have obtained genetic counseling actually completed an appointment. Women who discussed their BCRA results with their physicians were more compliant with a six month breast exam with a doctor (53% vs 17%, p = 0.018). Overall, women felt that the BCRA was helpful and did not cause undue stress or anxiety. Although the cohort's compliance with recommendations was suboptimal, physicians' interactions with their patients may have a positive influence on their compliance.
Introduction
In 2014, breast cancer was projected as the most common cancer diagnosis for American women with an estimated 232,670 cases of invasive breast cancer (Siegel et al. 2014) . Women are encouraged to follow national screening guidelines to aid in early detection of breast cancer and decrease mortality associated with breast cancer. A woman's awareness of her own breast cancer risk might influence her adherence to screening and recommendations for breast health care. A personalized breast cancer risk assessment (BCRA) is the recommendation of the National Comprehensive Cancer Network (NCCN) and the United States Preventive Services Task Force (USPSTF) for all women considering prevention of breast cancer who do not have a personal history of breast cancer (NCCN Guidelines V 1.2014 Breast Cancer Risk Reduction 2014a .
A woman's risk for breast cancer can be individualized based on known risk factors: age, family history, age at menarche, age at first live birth, abnormal breast biopsy, and others (NCCN Guidelines V 1.2014 Breast Cancer Risk Reduction 2014a . Several risk models can estimate a woman's lifetime risk for breast cancer, often rated as average, moderate, or high. These models can include Gail, Claus and TyrerCuzick among others, and each of these models has different benefits and limitations (Jacobi et al. 2009; Tchou and Morrow 2003) . Providing an accurate breast cancer risk Electronic supplementary material The online version of this article (doi:10.1007/s10897-016-0050-y) contains supplementary material, which is available to authorized users. assessment is needed in order to achieve the best risk-benefit ratio before implementing breast cancer screening or risk reduction modifications . Screening recommendations and medical management options should be adjusted for those who are determined to have an increased risk for breast cancer. Some of these recommendations may include commencing annual imaging at an earlier age, more frequent imaging, more frequent clinical breast exams, and others. In addition, the assessment may include a recommendation for genetic counseling based on personal and family history, regardless of breast cancer risk (NCCN Guidelines V 1.2014 Genetic/Familial High Risk Assessment: Breast and Ovarian Cancer 2014b).
Women's perceptions of their breast cancer risk are often higher or lower than their actual BCRA (Lerman et al. 1995) . Such misperception may result in these women not following appropriate screening measures (Scherer et al. 2013) . Furthermore, many women have experienced anxiety and distress due to their misconceptions about increased breast cancer risk (Mellon et al. 2008) . Given women's misconceptions about breast cancer risk, we implemented a new clinical service in September 2013 to provide a BCRA and evaluation for genetic counseling for women receiving screening mammograms.
In order to evaluate the utility of the BCRA, this study assessed women's perceptions of their cancer risk, their compliance with medical management recommendations, as well as communication with their physician regarding the BCRA outcome and recommendations for breast health care. We report the results for women whose BCRA indicated a high risk of developing breast cancer.
Methods Participants
Included in the study were women 18 years of age or older who underwent a screening mammogram performed at either of two designated imaging centers between September 23, 2013 (date the BCRA was initiated) and May 31, 2014, who chose to receive a complimentary BCRA, and who received the BCRA results and recommendations letter at least 6 months prior to mailing the study survey.
Procedures
At the time of screening mammography, all women completed a mammography history form (Appendix A) and indicated their choice to have a BCRA. For women who chose a BCRA, genetics department staff performed the BCRA by evaluating their lifetime breast cancer risk and hereditary breast cancer risk.
At our institution, we used one or more of three risk models as appropriate for each woman (Gail, Claus, and Tyrer-Cuzick) (Evans and Howell 2007) . The Gail model was performed for all women, the Claus was performed for those that reported a family history of breast cancer with known ages at diagnosis, and the Tyrer-Cuzick model was performed only for women that reported a family history of breast or ovarian cancer and/or personal history of breast biopsy. Breast biopsy outcomes were only added to the Tyrer-Cuzick model if reported as hyperplasia, atypical hyperplasia or lobular carcinoma in situ (LCIS). Women that reported an otherwise unspecified benign outcome or no outcome were reported as Bno benign disease^rather than Bunknown benign disease^as we feel the latter tends to overestimate risk.
The highest risk from the three models was assigned for each woman to capture all women who may be appropriate for additional breast health screening or risk reduction strategies including but not limited to breast MRI. The American Cancer Society recommends annual MRI for women with a 20% or greater lifetime risk of developing breast cancer based on models largely dependent on family history, women with a hereditary mutation like BRCA1 or BRCA2, and women who are an untested first degree relative of a known hereditary mutation carrier (Saslow et al. 2007) . Although the Gail model is not an approved model for recommending breast MRI, it can supply valuable information for estimating a woman's risk for breast cancer and evaluating modifications to her breast health care.
We defined average lifetime risk of breast cancer as less than 15%, moderate risk as 15-19%, and high risk as 20% or greater. Within each category, women were further categorized by meeting NCCN criteria for genetic counseling. Women with a prior history of breast cancer were not given a risk for breast cancer, but were still assessed for the need to have genetic counseling. Some women did not receive an assessment with recommendations due to incomplete information on a mammography history form.
Each woman and her physician who ordered the mammogram were mailed a letter disclosing the results of the BCRA and recommendations based on the BCRA (Appendix B). For women found to be at high risk, the letter gave the following NCCN recommendations: undergo a six month breast exam by a physician, consider annual breast MRI, and consider risk reduction strategies with your physician. The letter also gave OhioHealth recommendations to consider either an appointment with the high risk breast clinic or an appointment with a breast surgeon or breast specialist. In addition, some of these high risk women also received a recommendation for genetic counseling based on NCCN guidelines for genetic evaluation. Women at average and moderate risk also received breast cancer screening and genetic counseling recommendations as appropriate.
The genetics department staff used Progeny database (pedigree drawing and clinical database management software for genetic information) to identify eligible women who had a BCRA and received a letter of recommendations at least 6 months prior to the survey being mailed. The research staff mailed a 9-question survey, a survey cover letter (Appendices C-D), and a pre-paid return envelope to all qualifying women based on stratification from the statistical office. All women in the high risk group and moderate risk were included, whereas the RAND function in Microsoft Excel was used to randomly select a 15% sample from the complete list of women with average risk.
Completion and return of the survey implied patient consent, as stated in the consent cover letter. Although we collected data on all risk groups, we report results only for the high risk women because the NCCN recommendations are substantially different for this group, and compliance with these recommendations may have a greater impact on earlier cancer detection and mortality.
This study was reviewed and approved by the OhioHealth Institutional Review Board.
Statistical Analysis
This was a prospective, descriptive study. The study goals were to 1) compare women's perception of their breast cancer risk before and after the BCRA, 2) evaluate the effect of a recommendation for genetic counseling on a patient's perceived risk of cancer, her rating of the BCRA helpfulness, and her discussion with a physician, 3) determine how often women recalled the recommendations that they received by letter, and what factors influenced their recall, 4) evaluate compliance with the recommendations for breast health care and genetic counseling, 5) evaluate how often women discussed the BCRA results with their physicians and what impact those discussions had on compliance with recommendations, and 6) determine the proportion of women that thought the BCRA was valuable to them.
Demographic characteristics, including age, race, and insurance provider, and risk factors among women who were classified as high risk were reported using frequencies and percentages for categorical variables and means and standard deviations for continuous variables. Survey response rates were calculated. Demographic characteristics and risk factors of women who returned the survey were also reported and compared to those women who did not return the survey using two-sample t-tests, chi-square tests, and Fisher's exact tests. Statistical significance was set at p < 0.05 for all tests.
Calculations of frequencies and percentages describe the proportions of high risk women who reported their perceived risk changed as a result of the BCRA, thought the BCRA was helpful, and discussed the results of the BCRA with their physician. Chi-square and Fisher exact tests analyzed comparisons between groups. For each type of breast health care recommendation, we reported the proportions of women who already completed the recommendation, scheduled (or plan to schedule) the recommendation, or did not plan to schedule the recommendation.
Results
Based on our database (Progeny), 4114 women elected to have a BCRA when they presented for screening mammography (44% of the original 9388 who had screening mammograms). Of the 4114 women, 1233 did not meet inclusion criteria, leaving 2881 eligible women. The BCRA identified 309 women as high risk for developing breast cancer, 306 women as moderate risk, and 2266 women as average risk. Staff mailed surveys to everyone in the high risk and moderate risk groups, and 15% of the average risk group (total of 956 surveys).
Only data from the high risk group was analyzed. Of the 309 women in the high risk group, 69 returned the survey for a response rate of 22%, similar to the response rates of the average and moderate risk groups (20% and 22% respectively). High risk women ranged in age from 25 to 81 years. Of these 69 women in the high risk group, 1 (1%) was deemed high risk by the Gail model only. All other women were classified as high risk by the Claus and/or Tyrer-Cuzick models. Additionally, of the women that reported having had a breast biopsy, only 1 woman reported an outcome of hyperplasia, atypical hyperplasia or LCIS which would have influenced her risk. However, this woman also had a significant family history and her estimated risk for breast cancer is greater than 20% based on family history alone with the Claus model.
In order to detect possible bias that might influence which high risk women returned the survey we compared demographic variables and cancer risk factors of women who returned the survey to those who did not return the survey (Table 1) . Caucasians were significantly more likely to return the survey. No other demographic variable or risk factors were significantly associated with the return of surveys.
Women's Perceived Risk of Breast Cancer The survey asked women whether their own perception of breast cancer risk changed after taking the BCRA. The majority (65%) noticed no change in their perceived risk; 9% reported an increased perception of risk, whereas 27% actually felt that their risk decreased after the BCRA.
Impact of Recommendation for Genetic Counseling
Overall, 78% (n = 243) of women in the high risk group received a recommendation for genetic counseling, including 53 of the 69 who returned the survey. We explored whether that recommendation may have influenced several factors: perceived risk of cancer, opinion regarding helpfulness of the BCRA, and compliance with iscussing the BCRA outcome with her physician. Table 2 summarizes these associations. The recommendation for genetic counseling was not significantly related to any of these factors. Table 3 illustrates participant's recall of the recommendations in the letter sent to them. Less than one-third of the women remembered all health care recommendations. Approximately one-half of the women (35/ 69) recalled at least one recommendation, and one-half (34/ 69) recalled no recommendations. A woman's perceived risk of cancer after a BCRA was significantly associated with her recall of recommendations. Sixty-four percent of the women whose perceived risk was more than average remembered at least one recommendation, compared to 37% of those whose perceived risk was average (p = 0.03). However, this perceived risk was not associated with compliance. The proportion of women who were compliant with at least one of the recommended actions was similar between groups based on perceived risk: less than average -43%; average -37%; more than average -52% (p = 0.500). Table 4 shows the rate of compliance with health care recommendations for those high risk women who correctly recalled the recommendations. If the definition of compliance includes Bcompleted, scheduled, or planned,^then more than half the women were compliant with the recommendations for breast MRI, six month breast exam by a physician, and appointment with the high risk breast clinic or breast specialist. Both Bscheduled^and Bplan to schedule^were included in the definition of compliance to capture women whose responses showed a change in behavior by making a plan to proceed with breast health recommendation with intent to have these completed in the near future.
Compliance with the Breast Health Care and Genetic Counseling Recommendations
Lastly, 13 of the 53 (24%) high risk women who received a recommendation for genetic counseling recalled the recommendation, and of these 13 women, 5 (38%) were compliant with the recommendation.
Discussing the Results of the BCRA with a Physician The proportion of high risk women who discussed the BCRA results with their physician was 23% (16/69; 13 in person and 3 over the phone) ( Table 2) . Among the 16 women who discussed the results with their physician, 12 had been given recommendations for genetic counseling. As stated earlier, compliance for the recommendation of genetic counseling was not related to discussing the BCRA results with a physician.
On the other hand, discussion of BCRA results with a physician was significantly related to compliance with some recommendations. Women who discussed their BCRA results with their physician compared to those who did not discuss results were more compliant with a six month breast exam with a doctor (53% vs 17%, p = 0.018), and possibly more compliant with scheduling an appointment with a breast surgeon or specialist (46% vs 20.0%), p = 0.09) (Fig. 1) .
Value of BCRA to Women Overall, 68% of high risk women subjectively thought that the BCRA was very or somewhat helpful (Table 2) . Reasons included the following: it increased their knowledge (n = 33); it was reassuring (n = 27), and it changed their outlook or habits (n = 12).
Some high risk women thought the BCRA was not helpful because they were already aware of their risk (n = 9), the information was not clear (n = 7), they did not make any changes (n = 4), it increased their stress or anxiety (n = 3), and it increased cost of future care (n = 3).
As stated earlier, a recommendation for genetic counseling was not related to women's opinions on the helpfulness of the BCRA.
Discussion
The NCCN's recommendation for a personalized risk assessment for all women considering prevention of breast cancer and who do not have a personal history of breast cancer is resource intensive. This study was an attempt to evaluate the effectiveness and value of a BCRA in order to justify the resources necessary to provide a BCRA to all women at the time of screening mammography, a service our institution provided.
Overall, our survey results indicate that women felt that the BCRAwas helpful and it did not cause undue stress or anxiety. Although the cohort's compliance with both the breast health care recommendations and the recommendation to seek genetic counseling was suboptimal, physicians' interactions with their patients may have a positive influence on their compliance.
The proportion of high risk women returning the survey was 22%, comparable to response rates of other mailed surveys that provide no incentive for completion (Shih and Fan 2009) . Caucasians were significantly more likely to return the survey. While we cannot provide a definitive reason as to why Caucasian women were more likely to participate, others have had similar experience, reporting that African American individuals are less likely to participate in genetic research (Aagaard-Tillery et al. 2006; Espeland et al. 2006; Ford et al. 2006; Green et al. 2006; McQuillan et al. 2003; Mezuk et al. 2008; Moorman et al. 2004) .
The BCRA did not dramatically influence women's perceptions of their breast cancer risk. The majority, 65%, did not change their perception, and only 9% felt that their risk was increased after the BCRA. Previous studies have shown that women often misperceive their risk of developing breast cancer (Scherer et al. 2013 ). However, our findings are contrary to our bias that an individualized risk assessment would impact a woman's risk perception. One possible explanation is that the results were not directly communicated to the participant, but rather they were copied on the letter sent to their physician. This method of communication may not have been as impactful as personal communication. Additionally, a woman's perceived risk may be so dramatically influenced by personal and social experiences that a personalized risk assessment may have minimal impact on her current perception. Of course, another explanation may be that our cohort simply had a fairly good understanding of their risk prior to the BCRA.
Although the BCRA may not have altered the women's perceptions of their risk, the majority felt that the BCRA was helpful to them, mostly for knowledge gained and reassurance. Interestingly, only 3 participants stated that it increased their anxiety or stress, contrary to the findings of Mellon et al. (2008) ; thus, withholding a BCRA from women in the general population due to concerns about increasing a woman's anxiety may not be justified.
Since part of our BCRA included an evaluation of family history for recommending genetic counseling, we desired to investigate the cohort's compliance in completing a genetics evaluation and how the recommendation for counseling might have impacted the women's perception of cancer risk. We had anticipated that the recommendation for genetic counseling would have increased the participant's perceived risk and impacted compliance with recommendations. Genetic counseling and testing can identify a subset of these women who might have a hereditary predisposition for breast cancer, resulting in a substantially higher risk for breast cancer than estimated from the risk models. The results were unexpected. Only 24% of the women who received a recommendation for genetic counseling recalled the recommendation, and only 38% of those were compliant; thus, only 10% of women who should have obtained genetic counseling actually received it. Since the recommendation for genetic counseling did not appear to change risk perception and compliance, perhaps the correlation was not well understood by the participant. In the future, personally contacting women for whom genetic counseling is recommended may facilitate better understanding and compliance. Not only were women sub-optimally compliant in seeing genetic counselors, but we learned that women did not adequately recall the breast health recommendations detailed in the letters they received after the BCRA. One-half of the women recalled no recommendations. Even when they did recall the recommendations, compliance was less than ideal. The best compliance was 70% for the recommendation to have a six month breast exam. This compliance may be due to physician interaction as almost 43% of the women that recalled this recommendation also discussed it with their physician; or it may have been simply a result of women coincidentally scheduling their annual exam. Women were least compliant with the recommendation to utilize risk reduction strategies -17% of those who recalled the recommendation.
While the compliance rate with recommendations was less than desired, there is conflicting literature about the effect of perceived risk and compliance to breast cancer screening. Two large meta-analytic studies supported a greater adherence to breast cancer screening based on the severity of the perceived risk (Katapodi et al. 2004; McCaul et al. 1996) . However, Calvocoressi et al. (2004) and Royak-Schaler et al. (2002) found that despite past research showing a positive linear relationship between risk perception and compliance, it is now thought to be a much more complex relationship.
There are several other considerations that may explain the poor recollection of, and compliance with, the recommendations for the high risk women. The letter containing the BCRA results and recommendations was written to the physician and copied to the participant. Therefore, the language of the letter was above the standard fifth-grade reading level generally accepted for communications to the lay population; this could have resulted in poor understanding of the recommendations. Yet, the survey that was sent to women was written with the appropriate reading level. Also, the letter with recommendations and the survey contained subtle differences in the verbiage of the recommendations; this may have caused confusion and affected compliance. At the time the BCRA was completed, the option for annual breast MRI was still a consideration rather than a recommendation of the NCCN. Other options for changes in breast health practices also included the word consider. Therefore, the word consider possibly may have influenced a woman's understanding of how important these breast health practices were and whether they should be completed.
The most helpful correlation in this study was the association between the physician-patient interaction and a woman's compliance with the breast health recommendations. Although only a quarter of the women discussed the BCRA results with their physicians, a significantly greater proportions of these women (53%) saw a physician for a six month breast exam compared to the group who did not discuss results with their physicians (17%). In addition, compliance with scheduling an appointment with a breast surgeon or specialist was greater for women who interacted with their physician although the difference was not statistically significant. Given these results, we feel that physician involvement is important for encouraging high risk women to follow the appropriate breast health recommendations. This is also supported by Kostev et al. (2014) , which evaluated compliance of taking Tamoxifen or an aromatase inhibitor among women being treated for breast cancer and found that physician motivation and involvement significantly improved women's compliance with taking these medications. However, one could also speculate that the increased compliance could be the result of a motivated group of women that sought out their physician for input.
Should our institution continue to provide the BCRA to all women, a future goal would be to increase the physicianpatient interactions with the high risk women. Furthermore, we would want to determine the most appropriate physician to receive the BCRA information. In this project we mailed the results to the ordering physician, commonly a gynecologist, yet women might be seeing another primary care provider on a more frequent basis; therefore, sending the letter to multiple healthcare providers may be beneficial. We would need not only to consider the timing of the woman's next scheduled appointment with her physicians, but also to incorporate methods to encourage the physician-patient discussion of the results. Such methods might include follow-up phone calls to women and physician offices. Assistance from additional staff, such as breast health nurses or patient navigators, throughout the process could improve communication and understanding.
High compliance and adherence to NCCN guidelines for breast health care and genetic counseling might justify the significant resources expended to provide a BCRA to the general female population. As mentioned previously, there are several risk models that can be utilized to estimate a woman's risk for breast cancer, each with its own benefits and limitations. The intent of our institution's BCRA was to determine which individuals may have an increased risk for breast cancer based on family history and personal risk factors. We acknowledge that at the time of the BCRA, there was insufficient data to recommend for or against adjunct breast MRI for women with a history of atypical hyperplasia and LCIS. However, in 2015 the NCCN updated its breast cancer screening recommendations for these women and has since been recommending adjunct breast MRI. Therefore, implementing a BCRA program requires a continuous evaluation of the breast cancer screening recommendations for women who have an increased risk for breast cancer based on personal risk factors only, family history only or a combination of these factors.
Overall, our study leads us to believe that we need to take steps to increase women's recall of recommendations and compliance with those recommendations. Potential improvements include reformatting the letter of recommendations that women receive by using more patient-friendly wording and illustrations to show breast cancer risk level, and by removing ambiguous terms such as consider. Patient navigators could call all high risk women to discuss results and recommendations and assist in scheduling appointments for imaging, physicians, and genetic counselors. As mentioned above, efforts to increase the physician-patient interaction would be essential. Lastly, we may consider providing these women with brochures about genetic counseling and the breast health program to provide more details and answer frequently asked questions.
Limitations
The small number of high risk women raises the concern of beta statistical errors. The population receiving care at the selected imaging sites has an overall lower socioeconomic class (SEC) which theoretically may impact participant compliance with recommendations. However, we did not capture the SEC of the study participants and cannot objectively demonstrate this statement. As stated above, limited personnel resources prevented more personal contact with the cohort to explain the significance of genetic counseling and the importance of compliance with health care recommendations. We chose to define compliance to include both Bscheduled^and Bplan to schedule^actions on recommendations in order to identify behavior changes in this population; however, this may have resulted in an overestimation in our compliance rate and warrants consideration of separating these outcomes for future studies. Lastly, physician-patient interaction was found to be an important factor influencing patient compliance with breast health care recommendations but it is unknown which party initiated the interaction and deserves further study.
Practice Implications
The realization that a BCRA may not impact a woman's understanding of her cancer risk nor her compliance with health care recommendations should signal institutions and physicians to carefully assess the resources and processes necessary to offer a BCRA successfully to all women.
Traditionally, oncology genetic counselors send a detailed letter summarizing the risk assessment, genetic test results and options for cancer screening and prevention for the patient and family. However the lack of recall and compliance of our participants with the recommendations for breast health care and genetic counseling has prompted us to ask whether our genetic counseling patients will have the same response to their summary letter. Perhaps different methods for supplying this information to genetic counseling patients should be evaluated.
Research Recommendations
Noting that the physician-patient interaction was a significant factor in the cohorts' compliance with health care recommendations, future research could involve not only confirmation of this significance, but also designing methods to increase the physician-patient communication.
While there are clear guidelines for women who have a BRCA1/2 mutation or a lifetime risk for breast cancer of 20% or greater based on family history, the recommendations for women at moderate risk for breast cancer either by family history of the presence of a moderate risk gene mutation are less clear. As genetic testing for hereditary cancer risk continues to grow with the use multi-gene panels, the identification of women classified as moderate risk is also increasing. Therefore, this group of women would be an interesting cohort to study perception of risk and compliance with available recommendations.
